A stalled deal is a normal deal
Most IPO documentation reads as a straight line: prepare, market, price, list. In practice a material share of attempted listings never price. Windows close, books build only at prices the board cannot accept, or a fact emerges mid-process that changes the risk profile of the company. None of that is a defect in the process; it is a scenario the process has to be designed to survive.
The CFO's job is not to prevent a stall at any cost. It is to make sure that when the deal stops moving, the decision is made deliberately, the exit is executed in the right order, and the value already spent on readiness is not written off. This guide covers the decision, the contracts, the communications and the second attempt. For the mechanics of keeping a timetable on track in the first place, see the IPO process roadmap and the go/no-go gates and timetable slippage checklist.
Three different things get called "a postponement"
- A timetable slip. A phase runs long — audit, prospectus review, regulator comments, a late governance change. The economics of the deal are unchanged; only the calendar moves. The go/no-go gates checklist is built for this case.
- A window pause. The file is ready and the company is presentable, but demand is absent or the sector has fallen out of favour. The book is held, not released; the deal is re-tested in a later window.
- A withdrawal. The registration statement or prospectus is formally withdrawn or allowed to lapse, the book is released, allocated demand is stood down and advisers are stepped back. This has legal, contractual and reputational consequences that a pause does not.
Confusing the three is expensive. Teams that treat a withdrawal as a long pause under-invest in the legal and communication work; teams that treat a slip as a withdrawal burn credibility with investors for no reason.
The decision framework: price down, pause, or pull
Fix the floor before you need it
The price floor and the walk-away trigger should be decided in a board resolution before the offer period opens, not while the book is live and the CEO is negotiating with the lead bank at midnight. A workable board paper contains three numbers and one delegation: a minimum price, a minimum gross proceeds figure, and the conditions under which management may recommend not proceeding — together with a pricing committee empowered to act between board meetings. A board that has pre-agreed its floor can absorb a disappointing book without a crisis; a board that has not will price into weakness because the alternative feels like failure. Board composition and decision rights for listed-company life are covered in the board and committee readiness checklist.
Diagnose before you choose
There are three things that can be wrong — the price, the story, or the facts — and they call for different remedies.
| What the book shows | Most likely cause | First move | Owner |
|---|---|---|---|
| Cover exists, but only far below the range and only from lower-quality accounts | Expectation gap, not a broken story | Re-base the range on evidence, test anchor demand, go back to the board | CFO with lead bank |
| A thin book at almost any price, broad disinterest across the target list | Equity story is not landing, or the window for the sector has closed | Pause, rebuild the story and comparable set, re-test in a new window | CEO/CFO with advisers |
| Demand collapses on a specific new fact | Material new information: litigation, restatement, key-person, regulatory, cyber | Legal and disclosure review first; decide on a supplement or a pull | General counsel with CFO |
What pricing down actually costs
Cutting the range is not a neutral act. Consider the dilution effect on existing holders, the message sent to employees holding options at a strike fixed around the original range, the anchoring effect on the aftermarket, and the fact that a discounted deal can weaken demand further if investors infer that the issuer needed the money more than it needed the price. In markets where stabilisation is permitted it is a support mechanism, not a guarantee. The trade-offs belong in valuation and pricing and offer structure.
What pulling actually costs
Withdrawal spends fee budget without acquiring capital, demoralises the internal team, and uses up a scarce resource: investor patience. Investors who were brought into a story, only to see it withdrawn, will apply a discount to the next attempt — which is one reason the second launch must be materially different, not simply later.
Contractual exit points and break fees
Where the commitment attaches
The engagement or mandate letter frames the relationship but is generally not the point of no return. In most market practice the issuer's ability to walk away is lost or narrowed when the underwriting agreement is signed, typically close to pricing. Before that signature, exit is usually a matter of paying expenses; after it, exit depends on what the contract says.
Read the termination clauses before they matter, and know which one applies to your situation:
- market-out or material adverse change clauses, and what evidence they require;
- force majeure and disruption clauses;
- issuer breach of warranty or indemnity triggers, which become live the moment a new fact emerges;
- conditions precedent that have not been satisfied — for example absent comfort letters, legal opinions or listing approval.
Break fees and expense reimbursement
Practice here differs by venue, deal size and relative leverage, and evolves over time. Structures range from a straight reimbursement of documented expenses with an agreed cap, through fixed break fees, to termination payments that include warrants or shares in smaller offerings. Some are triggered only by a no-fault termination by the issuer; others by any withdrawal. Whatever the structure, it is normally negotiated at mandate stage, when the issuer has the most leverage. Trying to negotiate a break fee while pulling a deal is among the most expensive conversations in corporate finance. Budget for the possibility from the start — the IPO cost budget tool and what an IPO costs cover the categories.
Withdrawal mechanics are jurisdiction-specific
There is no universal procedure. Three labelled examples:
- In the US, an issuer withdraws a registration statement by filing an application on Form RW under Rule 477 (17 CFR 230.477), which must state that no securities were sold; the application becomes effective unless the regulator objects within a set period. Separate rules address how an abandoned public offering interacts with a subsequent private placement (Rule 155) and the treatment of filing fees already paid.
- In the EU, a prospectus is valid for twelve months after approval (Article 12, Regulation (EU) 2017/1129), so a short pause inside that window may not require a fresh prospectus. But a material new factor triggers a supplement, and investors who subscribed before its publication may have withdrawal rights under Article 23 of the same regulation. Withdrawing before allocation and settlement is legally far cleaner than unwinding after it.
- Where securities have already been allotted, the question stops being a communications exercise. Investor withdrawal rights, unwind mechanics, buy-back or compensation questions, settlement and market-abuse analysis all come into play. Bring counsel in before the decision, not after.
Also notify the exchange and any sponsor or nominated adviser under the venue's own regime, and check whether market-abuse disclosure obligations already apply once admission to trading has been requested — see disclosure controls and market abuse.
Communications: the hardest deliverable
Employees first, always
If the internal team learns about a withdrawal from the press, the cost is months of lost trust. Prepare a manager script and an FAQ before the decision is taken — not after. Be explicit about what does not change: salaries, the operating plan, the projects funded by the expected proceeds. Be careful with equity: options and share plans carry their own communication and tax constraints, covered in the employee share plans checklist.
The board and the shareholder register
Document the decision and the reasoning contemporaneously. A board minute that records the evidence, the alternative considered and the criteria applied is worth a great deal when the company later raises privately or re-launches, and it protects directors.
Two investor audiences
The accounts that were allocated or nearly allocated deserve a personal call from the CEO or CFO with the relevant banker. Keep it factual: what happened, what the company will do next, no re-litigating of the price and no blame directed at named investors. The accounts that passed deserve less contact but should not be left to read it in the news with no context.
Media and rumour
One spokesperson, one short written statement, no wandering off-script. If the reason was valuation or an issuer-specific fact, saying "adverse market conditions" when the market was demonstrably open damages credibility that the re-launch will need.
Preserving the readiness investment
Much of what an IPO programme produces is reusable, and much of it decays quickly. Distinguish the two deliberately.
- What survives: governance and committee structures, audit-ready accounts, the reporting and consolidation systems, the data room, the equity story research, and the investor feedback file.
- What decays: the prospectus text as the business moves on, financial information once a new reporting period begins, DRHP-style disclosure against a changed group structure, and — fastest of all — investor enthusiasm and analyst familiarity.
Keep the data room warm with quarterly updates, keep the financial calendar at listed-company discipline even unlisted (see finance and reporting readiness), and write down every investor objection with the account name and the price at which interest stopped. That file, not the prospectus, is what makes the second attempt efficient. Then separate genuinely sunk cost from the incremental cost of a re-launch, and negotiate with advisers over rollover of fees or re-engagement credits while the relationship is still warm.
The second attempt is a new deal
Timing
Re-launch when the specific reason for the withdrawal has been resolved — the window reopened, the story was rebuilt, or the numbers crossed a threshold investors named. Do not re-launch into a closing window simply because the file is ready: a second failure is far more damaging than a first. Avoid dates that invite direct comparison with the first attempt, and check the sector calendar for competing deals and index or results events.
Valuation and structure
The relevant anchor is where the last book actually cleared, not the original range. Expect to re-test the range from evidence, consider a smaller offer with a deliberate free float, and revisit structure — size, mix of primary and secondary, lock-ups and over-allotment. See offer structure and marketing, bookbuilding and pricing.
Team and syndicate
Rotating part of the syndicate, or changing the lead, can signal that something is genuinely different. Re-examine adviser economics in light of what was actually delivered. Internally, replace or reinforce whoever carried the first attempt through its worst weeks — the same people running the same process in the same way rarely produce a different outcome.
Alternatives worth pricing honestly
A second attempt is one option among several: a private growth round, debt, a partial secondary sale, a different venue or segment, or a different route to market entirely. Compare them on the same basis — certainty of execution, dilution, control and time — rather than treating the IPO as the default. Choosing a listing venue and SPACs, direct listings and IPOs set out the alternatives.
A withdrawal executed in the right order — decision documented, contracts read, employees told first, regulators and exchange notified, readiness preserved, feedback recorded — is not a failed IPO. It is a sequencing decision. The second attempt is a new transaction with new evidence, and it should be built as one.